跳至主要内容
临床试验/NCT03273881
NCT03273881招募中不适用

Effect of Intrapartum Glucose With Compared to Without Constant Intravenous Insulin on Neonatal Hypoglycemia Among Diabetic Women. A Randomized Controlled Trial

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年10月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Neonatal hypoglycemia

研究概览

简要总结

This study aims to examine the effect of intrapartum treatment of diabetic women with combined glucose and constant insulin infusion compared to glucose alone on the incidence of neonatal hypoglycemia. Pregnant women with diabetes in pregnancy will be randomly divided during labor to 2 groups: group 1, will receive intravenous glucose with constant insulin infusion; group 2 will receive intravenous glucose alone. The primary outcome is the incidence of neonatal hypoglycemia.

详细描述

About 2 to 9% of pregnant women are diagnosed with gestational diabetes. Peripartum complications attributed to diabetes include: birth trauma, neonatal hypoglycemia and hyperinsulinemia and neonatal hyperbilirubinemia. The incidence of neonatal hypoglycemia is about 40%. Strict glycemic control may lower the risk of neonatal complications. There is a lack of evidence on how to manage women with diabetes during labor. Previous studies recommended the use of intravenous saline solution boosted with 5% glucose and insulin as needed, glucose 5% with constant insulin infusion and others recommended the use lactated Ringer's solution. Most of these studies are either retrospective or have a small number of participants.

In this study we will examine the effect of 2 different protocols on glycemic control during labor and the immediate neonatal period. Women in group 1, will receive intravenous saline solution boosted with 5% glucose and constant insulin infusion. Women in group 2, will receive intravenous saline solution boosted with 5% glucose alone. The desirable intrapartum glucose level will be 70 to 100 mg/dL. Glucose levels will be checked hourly. Women in both groups will receive additional insulin infusion in cases of glucose levels above 100 mg/dL. Additionally, the 5% glucose solution will be substitute with lactated Ringer's solution in cases of glucose levels above 140 mg/dL.

Intravenous fluid regimens will be assigned according to a computer randomization sequence generation program. Women will randomly assigned to the 2 groups in a 1:1 ratio. The randomization sequence results will be kept in the delivery ward in a closed study box. Site investigators will enroll participants after confirming eligibility. The sequence will be concealed until intervention is assigned (and after obtaining a signed informed consent).

Our hypothesis is that 5% glucose combined with constant insulin infusion will achieve better glycemic control and thus will lead to lower rate of neonatal hypoglycemia. In order to detect a reduction of neonatal hypoglycemia from 40% to 20%, 182 women will be needed in both groups in order to achieve a level of significance of 95% (α, 2-sided = 0.05) and a power of 80% (β = 0.2).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • >37 weeks gestation
  • gestational diabetes mellitus according to Carpenter and Coustan
  • pregestational diabetes mellitus

排除标准

  • Intrauterine fetal death
  • estimated fetal weight<10p
  • multiple gestation
  • major fetal malformations

研究组 & 干预措施

glucose solution and insulin

Active Comparator

Participants will receive intravenous saline solution boosted with 5% glucose + 8 units regular insulin in a rate of 125 mL/h.

干预措施: glucose solution and Insulin (Drug)

glucose solution and insulin

Active Comparator

Participants will receive intravenous saline solution boosted with 5% glucose + 8 units regular insulin in a rate of 125 mL/h.

干预措施: glucose solution only (Drug)

glucose solution only

Active Comparator

Participants will receive intravenous saline solution boosted with 5% glucose in a rate of 125 mL/h.

干预措施: glucose solution and Insulin (Drug)

结局指标

主要结局

Neonatal hypoglycemia

时间窗: 2-3 hours postpartum

about 2-3 hours postpartum the neonate will have a capillary glucose test

次要结局

  • Length of neonatal hospital stay(30 days)
  • NICU admission(48 hours)
  • Maternal glycemic control during labor(24 hours)
  • Mode of delivery(1 hour)
  • Neonatal APGAR score(5 minutes)
  • Umbilical cord glucose level(30 minutes)
  • The need for neonatal IV glucose infusion(48 hours)
  • Maternal urine ketones(1 hour)
  • Total amount of regular insulin during labor(24 hours)
  • Umbilical cord PH(30 minutes)
  • Length of delivery(24 hours)
  • Breastfeeding(48 hours)
  • Neonatal jaundice(48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gali Garmy

Dr Gali Garmi

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验